VTGN Vistagen Therapeutics, Inc.

Fundamentals / CIK 0001411685 / USD

Vistagen Therapeutics, Inc. reported $2.38M in revenue and a net loss of $58.94M for the trailing twelve months ended September 30, 2026 (down 46.5% year over year), with a -2541.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VTGN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$8.61M$4.30M$0-$65.26MFY 2017 Revenue: $1.25MFY 2017 Net Income: -$10.26M2017FY 2018 Revenue: $0FY 2018 Net Income: -$14.35M2018FY 2019 Net Income: -$24.59M2019FY 2020 Revenue: $0FY 2020 Net Income: -$20.77M2020FY 2021 Revenue: $1.09MFY 2021 Net Income: -$17.93M2021FY 2022 Revenue: $1.11MFY 2022 Net Income: -$47.76M2022FY 2023 Revenue: -$227KFY 2023 Net Income: -$59.25M2023FY 2024 Revenue: $1.06MFY 2024 Net Income: -$29.36M2024FY 2025 Revenue: $486KFY 2025 Net Income: -$51.42M2025FY 2026 Revenue: $1.27MFY 2026 Net Income: -$69.69M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Revenue $1.27M $486K $1.06M -$227K $1.11M $1.09M $0 -- $0 $1.25M
Research & Development $54.97M $39.38M $20.02M $44.38M $35.41M $11.93M $13.37M $17.10M $7.76M $5.20M
Total Operating Expenses $73.39M $56.46M $34.09M $59.04M $48.89M $19.02M $20.80M $24.56M $14.20M $11.50M
Operating Income -$72.13M -$55.97M -$33.02M -$59.27M -$47.78M -$17.93M -$20.80M -$24.56M -$14.20M -$10.25M
EBITDA -$71.93M -$55.82M -$32.89M -$59.14M -$47.63M -$17.82M -$20.70M -$24.47M -$14.12M -$10.19M
Interest Expense -- -- -- -- -- -- -- $8.0K $8.9K $4.6K
Income Before Tax -$69.68M -$51.41M -$29.36M -$59.24M -$47.76M -$17.93M -$20.77M -$24.59M -$14.34M -$10.25M
Income Tax Expense $7.0K $7.0K $4.0K $6.0K $3.4K $2.6K $2.6K $2.6K $2.4K $2.4K
Net Income -$69.69M -$51.42M -$29.36M -$59.25M -$47.76M -$17.93M -$20.77M -$24.59M -$14.35M -$10.26M
Basic EPS -$1.83 -$1.67 -$1.52 -$8.51 -$7.38 -$14.71 -$15.02 -$27.03 -$33.63 -$46.25
Diluted EPS -$1.83 -$1.67 -$1.52 -$8.51 -- -$14.71 -$15.02 -$27.03 -$33.63 -$46.25
Basic Shares Outstanding 38.1M 30.9M 19.4M 7.0M 6.6M 2.9M 1.5M 951.1K 462.5K 250.8K
Diluted Shares Outstanding 38.1M 30.9M 19.4M 7.0M -- 2.9M 1.5M 951.1K 462.5K 250.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $138K $1.48M $465K $303K $258K $244K -$15K $234K
Research & Development $6.55M $10.91M $13.06M $14.22M $15.91M $11.68M $10.21M $11.30M
Total Operating Expenses $11.07M $14.82M $17.18M $19.85M $20.31M $16.05M $14.48M $15.35M
Operating Income -$10.94M -$13.35M -$16.72M -$19.55M -$20.05M -$15.80M -$14.49M -$15.12M
EBITDA -$10.89M -$13.30M -$16.66M -$19.49M -$20.00M -$15.76M -$14.46M -$15.08M
Income Before Tax -$10.74M -$13.03M -$16.27M -$18.90M -$19.42M -$15.10M -$13.63M -$14.09M
Income Tax Expense $0 $0 $7.0K $0 $0 $0 $0 $0
Net Income -$10.74M -$13.03M -$16.27M -$18.90M -$19.42M -$15.10M -$13.63M -$14.09M
Basic EPS -$0.24 -$0.30 -- -$0.45 -$0.54 -$0.47 -- -$0.46
Diluted EPS -$0.24 -$0.30 -- -$0.45 -$0.54 -$0.47 -- -$0.46
Basic Shares Outstanding 44.4M 43.0M -- 42.2M 35.7M 31.9M -- 30.7M
Diluted Shares Outstanding 44.4M 43.0M -- 42.2M 35.7M 31.9M -- 30.7M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents $30.79M $67.13M $119.2M $16.64M $68.14M $103.1M $1.36M $13.10M $10.38M $2.92M
Short-Term Investments $14.61M $13.35M $0 -- -- -- -- -- -- --
Cash & Short-Term Investments $45.40M $80.50M $119.2M $16.64M $68.14M $103.1M $1.36M $13.10M $10.38M $2.92M
Total Current Assets $46.94M $82.08M $120.7M $17.51M $71.00M $104.1M $1.58M $13.63M $11.02M $3.38M
Property, Plant & Equipment, Net $427K $476K $435K $507K $414K $367K $210K $313K $207K $286K
Other Non-Current Assets $393K $454K $726K -- -- -- $48K $48K $48K $48K
Total Non-Current Assets $1.62M $2.27M $2.98M $3.58M $3.65M $4.16M $4.19M $383K $255K $334K
Total Assets $48.56M $84.34M $123.7M $21.09M $74.64M $108.3M $5.77M $14.01M $11.28M $3.71M
Accounts Payable $1.53M $653K $1.55M $2.47M $2.76M $838K $1.84M $1.05M $1.20M $867K
Deferred Revenue (Current) $1.71M $2.59M $791K $714K $1.24M $1.42M $0 -- -- --
Total Current Liabilities $12.79M $12.61M $5.12M $4.57M $5.77M $4.19M $27.71M $2.80M $1.46M $1.37M
Deferred Revenue (Non-Current) $0 $391K $2.67M $2.31M $1.56M $2.49M $0 -- -- --
Total Non-Current Liabilities $249K $1.34M $4.24M $4.44M $4.16M $12.11M $8.73M $4.14M $2.90M $1.73M
Total Liabilities $13.04M $13.95M $9.37M $9.01M $9.93M $16.30M $11.50M $6.94M $4.36M $3.10M
Total Debt (incl. Leases) $948K $1.51M $2.12M $2.61M $3.04M $3.72M $4.04M $9.3K -- --
Common Stock $40K $29K $27K $7.0K $6.9K $181K $49K $43K $23K $9.0K
Retained Earnings -$477.3M -$407.6M -$356.2M -$326.9M -$267.6M -$219.8M -$201.9M -$181.1M -$156.5M -$142.0M
Accumulated Other Comp. Income -$2.0K $5.0K $0 -- -- -- -- -- -- --
Total Stockholders' Equity $35.52M $70.39M $114.3M $12.08M $64.72M $91.98M -$5.73M $7.08M $6.92M $616K
Total Equity $35.52M $70.39M $114.3M $12.08M $64.72M $91.98M -$5.73M $7.08M $6.92M $616K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $10.89M $16.99M $30.79M $47.37M $62.79M $48.98M $67.13M $74.72M
Short-Term Investments $9.14M $14.74M $14.61M $14.40M $14.39M $14.20M $13.35M $13.85M
Cash & Short-Term Investments $20.00M $31.70M $45.40M $61.80M $77.20M $63.20M $80.50M $88.60M
Total Current Assets $22.29M $34.31M $46.94M $63.24M $78.93M $66.72M $82.08M $89.94M
Property, Plant & Equipment, Net $325K $375K $427K $480K $516K $530K $476K $428K
Other Non-Current Assets $289K $392K $393K $392K $405K $472K $454K $477K
Total Non-Current Assets $1.13M $1.43M $1.62M $1.81M $2.00M $2.21M $2.27M $2.37M
Total Assets $23.42M $35.74M $48.56M $65.06M $80.93M $68.92M $84.34M $92.31M
Accounts Payable $1.08M $1.00M $1.53M $1.28M $1.83M $486K $653K $1.04M
Deferred Revenue (Current) $96K $234K $1.71M $2.00M $2.14M $2.51M $2.59M $2.51M
Total Current Liabilities $8.43M $11.19M $12.79M $13.53M $13.64M $11.15M $12.61M $9.62M
Deferred Revenue (Non-Current) $0 $0 $0 $176K $336K $221K $391K $454K
Total Non-Current Liabilities $0 $63K $249K $607K $946K $1.00M $1.34M $1.56M
Total Liabilities $8.43M $11.26M $13.04M $14.14M $14.59M $12.16M $13.95M $11.19M
Total Debt (incl. Leases) $610K $783K $948K $1.05M $1.21M $1.42M $1.51M $1.71M
Common Stock $46K $44K $40K $40K $39K $29K $29K $28K
Retained Earnings -$501.1M -$490.3M -$477.3M -$461.0M -$442.1M -$422.7M -$407.6M -$394.0M
Accumulated Other Comp. Income -$11K -$7.0K -$2.0K $13K $14K $1.0K $5.0K $11K
Total Stockholders' Equity $14.99M $24.48M $35.52M $50.92M $66.34M $56.77M $70.39M $81.12M
Total Equity $14.99M $24.48M $35.52M $50.92M $66.34M $56.77M $70.39M $81.12M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income -$69.69M -$51.42M -$29.36M -$59.25M -$47.76M -$17.93M -$20.77M -$24.59M -$14.35M -$10.26M
Depreciation & Amortization $199K $150K $127K $130K $154K $118K $103K $91K $81K $55K
Stock-Based Compensation $4.00M $4.32M $2.18M $3.34M $3.48M $2.31M $3.82M $3.44M $2.34M $851K
Operating Cash Flow -$66.44M -$42.10M -$25.81M -$49.72M -$45.26M -$12.07M -$15.76M -$14.53M -$9.06M -$7.26M
Capital Expenditure -- -- $0 -$528K -$200K -$275K $0 -$174K -$1.6K -$239K
Free Cash Flow -- -- -$25.81M -$50.24M -$45.46M -$12.35M -$15.76M -$14.70M -$9.06M -$7.50M
Purchases of Investments -$22.30M -$24.98M $0 -- -- -- -- -- -- --
Investing Cash Flow -$877K -$13.15M -$61K -$740K -$200K -$275K $0 -$174K -$1.6K -$239K
Common Stock Issued $8.0K $0 $93.45M $0 -- $12.96M $3.35M $17.04M $16.72M $9.90M
Financing Cash Flow $30.97M $3.21M $128.4M -$1.04M $10.48M $114.1M $4.01M $17.42M $16.52M $9.99M
Net Change in Cash -$36.34M -$52.03M $102.5M -$51.50M -$34.97M $101.8M -$11.75M $2.72M $7.46M $2.49M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$10.74M -$13.03M -$16.27M -$18.90M -$19.42M -$15.10M -$13.63M -$14.09M
Depreciation & Amortization $50K $52K $52K $54K $53K $40K $40K $39K
Stock-Based Compensation $907K $991K $889K $1.10M $1.10M $916K $963K $1.08M
Operating Cash Flow -$12.16M -$14.71M -$16.20M -$17.63M -$13.76M -$18.85M -$10.06M -$10.28M
Purchases of Investments -$962K -$5.60M -$5.67M -$5.87M -$2.03M -$8.72M -$3.92M -$2.42M
Investing Cash Flow $5.71M $0 -$99K $104K -$94K -$788K $527K -$422K
Common Stock Issued $351K $928K -- $2.31M $27.93M $397K -- $1.06M
Financing Cash Flow $351K $909K -$283K $2.11M $27.65M $1.49M $1.95M $1.17M
Net Change in Cash -$6.10M -$13.80M -$16.58M -$15.41M $13.80M -$18.15M -$7.58M -$9.53M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Operating Margin -5683.7% -11517.1% -3103.5% -- -4308.3% -1646.1% -- -- -- -819.9%
Net Profit Margin -5491.3% -10579.8% -2759.6% -- -4306.8% -1646.1% -- -- -- -820.4%
Return on Equity (ROE) -196.2% -73.0% -25.7% -490.5% -73.8% -19.5% -- -347.5% -207.4% -1665.4%
Return on Assets (ROA) -143.5% -61.0% -23.7% -280.9% -64.0% -16.6% -359.9% -175.5% -127.2% -276.3%
Current Ratio 3.67x 6.51x 23.55x 3.83x 12.32x 24.85x 0.06x 4.87x 7.56x 2.47x
Quick Ratio 3.55x 6.38x 23.27x 3.64x 11.82x 24.61x 0.05x 4.68x 7.12x 2.14x
Debt to Equity 0.03x 0.02x 0.02x 0.22x 0.05x 0.04x -- 0.00x -- --
Revenue Growth (YoY) +161.1% -54.3% -- -120.5% +1.8% -- -- -- -100.0% --
5Y Revenue / Share Growth -91.2% -- -- -- -96.6% -- -- -- -100.0% --
10Y Revenue / Share Growth -- -- -- -100.6% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -2541.9% -2784.3% -5678.7% -8847.8% -9080.7% -9233.1% -11517.1% -7569.8%
Net Profit Margin -2474.5% -2702.6% -5487.0% -8486.8% -8631.9% -8634.7% -10579.8% -6777.1%
Return on Equity (ROE) -393.2% -276.2% -196.2% -131.7% -93.8% -98.3% -73.0% -58.3%
Return on Assets (ROA) -251.7% -189.2% -143.5% -103.1% -76.9% -80.9% -61.0% -51.2%
Current Ratio 2.64x 3.07x 3.67x 4.67x 5.79x 5.98x 6.51x 9.35x
Quick Ratio 2.37x 2.83x 3.55x 4.57x 5.66x 5.67x 6.38x 9.21x
Debt to Equity 0.04x 0.03x 0.03x 0.02x 0.02x 0.03x 0.02x 0.02x
Revenue Growth (YoY) -46.5% +504.9% -- +29.5% +41.0% +190.5% -107.6% -43.1%
Source: SEC EDGAR CompanyFacts (CIK 0001411685) · from March 31, 2000 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal